302 Followers on Owler
XOMA is a biotechnological company that focuses on the discovery and development of antibody therapeutics...
Read moreXOMA is a biotechnological company that focuses on the discovery and development of antibody therapeutics...
Read more
1981
PublicIndependent CompanyNASDAQXOMA
News
Mar 21, 2023
BioSpace
XOMA: XOMA Declares Quarterly Preferred Stock Dividends - March 21, 2023
Mar 21, 2023
Seeking Alpha
XOMA: XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend
Mar 10, 2023
Yahoo
XOMA: XOMA Full Year 2022 Earnings: Revenues Beat Expectations, EPS In Line
Mar 09, 2023
Owler
XOMA Corp.: XOMA's employee count changed from 12 in Mar 2022 to 13 in Mar 2023
Mar 09, 2023
FinanzNachrichten
XOMA: XOMA Corporation: XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy
Feb 28, 2023
Benzinga
XOMA: XOMA to Present at 43rd Annual Cowen Health Care Conference
Feb 17, 2023
Global Legal Chronicle
XOMA: Amolyt Pharma's Research Agreement and Licensing Option with XOMA
Jan 07, 2023
Life Care News
XOMA: XOMA Announces New Employment Inducement Grants Under
Nov 25, 2022
startupticker
XOMA: Obseva sells rights to its preterm labor treatment for up to $115 million
Nov 24, 2022
Medthority
XOMA: ObsEva announces sale of ebopiprant license agreement to XOMA for up to $113 Million.
Looking for similar companies to XOMA?
XOMA Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$6M
XOMA's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 29.8B. Over the last four quarters, XOMA's revenue has decreased by 52%. Specifically, in Q3 2022's revenue was $ < 1M; in Q2 2022, it was $ < 1M; in Q1 2022, it was $3.1M; in Q3 2021, XOMA's revenue was $ < 1M.
XOMA News
XOMA Blogs
XOMA Press Releases
XOMA Headquarters
XOMA Summary
ABOUT
Overview
XOMA is a biotechnological company that focuses on the discovery and development of antibody therapeutics. XOMA was founded in 1981. XOMA's headquarters is located in Emeryville, California, USA 94608. XOMA's CEO, James R. Neal, currently has an appr...CEO
XOMA's CEO, James R. Neal, currently has an approval rating of 84%. XOMA's primary competitors are Novartis, XBiotech, EyePoint Pharmaceuticals and 11 more.Website
xoma.comCompetitors
View 14 XOMA competitors here.Acquisitions
View 1 companies acquired by XOMA here.Funding
View XOMA funding details.Investments
Recent investment data cannot be found related to XOMAFrequently Asked Questions about XOMA
When was XOMA founded?
XOMA was founded in 1981Who is XOMA's CEO?
XOMA's CEO is James R. NealHow much revenue does XOMA generate?
XOMA generates $6M in revenueHow much funding does XOMA have?
XOMA has historically raised $42M in funding
Where is XOMA's headquarters?
XOMA's headquarters is in Emeryville California, USAHow many employees does XOMA have?
XOMA has 10 employeesWhat sector does XOMA operate in?
XOMA is in Pharmaceuticals, BiotechnologyWho are XOMA's competitors?
XOMA's top competitors are Novartis, XBiotech, EyePoint Pharmaceuticals